Cost reduction strategy for secondary prevention of stroke using cost-minimization analysis of antiplatelet drugs

被引：0

|

作者：

Donato, MLI

Silver, B

机构：

来源：

ANNALS OF NEUROLOGY | 2004年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S14 / S14

页数：1

相关论文

共 50 条

[1] Cost minimization and the number needed to treat in the secondary prevention of stroke with antiplatelet medications
Donato, ML
STROKE, 2000, 31 (11) : 2797 - 2797
[2] The pharmacoeconomics of neuromuscular blocking drugs: A perioperative cost-minimization strategy in children
Splinter, WM
Isaac, LA
ANESTHESIA AND ANALGESIA, 2001, 93 (02): : 339 - 344
[3] The death of cost-minimization analysis?
Briggs, AH
O'Brien, BJ
HEALTH ECONOMICS, 2001, 10 (02) : 179 - 184
[4] CHOLEDOCHOSCOPY - A COST-MINIMIZATION ANALYSIS
NAGORNEY, DM
LOHMULLER, JL
ANNALS OF SURGERY, 1990, 211 (03) : 354 - 359
[5] A COST-MINIMIZATION ANALYSIS OF CARBETOCIN FOR THE PREVENTION OF POSTPARTUM HEMORRHAGE IN CANADA
Mills, F.
Siu, E.
Poinas, A. C.
Chamy, C.
VALUE IN HEALTH, 2014, 17 (03) : A161 - A161
[6] Cost effectiveness of new antiplatelet agents in secondary stroke prevention
Kernan, WN
Fayad, P
Rizzo, JA
STROKE, 2001, 32 (01) : 332 - 333
[7] Secondary prevention of stroke with antiplatelet drugs
Diener, HC
MEDIZINISCHE KLINIK, 2004, 99 : 21 - 25
[8] Antiplatelet drugs in secondary stroke prevention
Belousov, YB
ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2003, : 88 - 89
[9] Antiplatelet drugs in secondary prevention of stroke
Diener, HC
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1998, 52 (02) : 91 - 97
[10] Cost-minimization Analysis of Drugs Used in the Treatment of Asthma and COPD Diseases in India
Payal, Billu
Kumar, Anoop
Saxcna, Harsh
CURRENT DRUG THERAPY, 2021, 16 (01) : 83 - 88

← 1 2 3 4 5 →